{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:19:58Z","timestamp":1779909598928,"version":"3.53.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/08617-7"],"award-info":[{"award-number":["2013\/08617-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/23620-0"],"award-info":[{"award-number":["2019\/23620-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2020\/06982-3"],"award-info":[{"award-number":["2020\/06982-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["430205\/2018-0"],"award-info":[{"award-number":["430205\/2018-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305353\/2023-3"],"award-info":[{"award-number":["305353\/2023-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["code 001"],"award-info":[{"award-number":["code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12010-025-05388-w","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:50:39Z","timestamp":1760172639000},"page":"7531-7551","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Industrial Production of PEGylated L-asparaginase: Process Design and Techno-economic Assessment Through Simulation"],"prefix":"10.1007","volume":"197","author":[{"given":"Adamo","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Sgrignoli","family":"Fuganholi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina S. R.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin Mariana","family":"Torres-Obreque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0691-5028","authenticated-orcid":false,"given":"Rafael","family":"G. Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5268-8690","authenticated-orcid":false,"given":"Adalberto","family":"Pessoa-Jr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0696-4663","authenticated-orcid":false,"given":"Adriano Rodrigues","family":"Azzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,11]]},"reference":[{"key":"5388_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fbioe.2018.00212","volume":"6","author":"LP Brumano","year":"2019","unstructured":"Brumano, L. P., da Silva, F. V. S., Costa-Silva, T. A., Apolin\u00e1rio, A. C., Santos, J. H. P. M., Kleingesinds, E. K., Monteiro, G., Rangel-Yagui, C. O., Benyahia, B., & Junior, A. P. (2019). Development of L-asparaginase biobetters: Current research status and review of the desirable quality profiles. Frontiers in Bioengineering and Biotechnology., 6, 1\u201322. https:\/\/doi.org\/10.3389\/fbioe.2018.00212","journal-title":"Frontiers in Bioengineering and Biotechnology."},{"key":"5388_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12032-023-02014-9","volume":"40","author":"M Tosta P\u00e9rez","year":"2023","unstructured":"Tosta P\u00e9rez, M., Herrera Bel\u00e9n, L., Letelier, P., et al. (2023). L-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: A comprehensive review. Medical Oncology, 40, 150. https:\/\/doi.org\/10.1007\/s12032-023-02014-9","journal-title":"Medical Oncology"},{"key":"5388_CR3","unstructured":"Brazilian National Institute of Cancer. Estimative (2020) Cancer incidence in Brazil. Available at: https:\/\/www.inca.gov.br\/sites\/ufu.sti.inca.local\/files\/\/media\/document\/\/estimativa-2020-incidencia-de-cancer-no-brasil.pdf. Accessed 06 Oct. 2024."},{"key":"5388_CR4","doi-asserted-by":"publisher","unstructured":"Tallal, L., Tan, C., Oettgen, H., Wollner, N., McCarthy, M., Helson, L., Burchenal, J., Karnofsky, D. Murphy, M. L. (1970) E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children. Cancer. 25(2),306\u2013320. https:\/\/doi.org\/10.1002\/1097-0142(197002)25:2<306::aid-cncr2820250206>3.0.co;2-h.","DOI":"10.1002\/1097-0142(197002)25:2<306::aid-cncr2820250206>3.0.co;2-h"},{"key":"5388_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/1097-0142(1971)28:4<819::aid-cncr2820280403>3.0.co;2-9","volume":"4","author":"WW Sutow","year":"1971","unstructured":"Sutow, W. W., Garcia, F., Starling, K. A., Williams, T. E., Lane, D. M., & Gehan, E. A. (1971). L-asparaginase therapy in children with advanced leukemia. The Southwest Cancer Chemotherapy Study Group. Cancer, 4, 819\u2013824. https:\/\/doi.org\/10.1002\/1097-0142(1971)28:4%3c819::aid-cncr2820280403%3e3.0.co;2-9","journal-title":"Cancer"},{"key":"5388_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1040-8428(98)00015-8","volume":"28","author":"HJ Muller","year":"1998","unstructured":"Muller, H. J., & Boos, J. (1998). Use of L-asparaginase in childhood ALL. Critical Reviews in Oncology\/Hematology., 28, 97\u2013113. https:\/\/doi.org\/10.1016\/S1040-8428(98)00015-8","journal-title":"Critical Reviews in Oncology\/Hematology."},{"issue":"49","key":"5388_CR7","doi-asserted-by":"publisher","first-page":"19952","DOI":"10.1074\/jbc.R117.819060","volume":"292","author":"CL Lomelino","year":"2017","unstructured":"Lomelino, C. L., Andring, J. T., McKenna, R., & Kilberg, M. S. (2017). Asparagine synthetase: Function, structure, and role in disease. Journal of Biological Chemistry, 292(49), 19952\u201319958. https:\/\/doi.org\/10.1074\/jbc.R117.819060","journal-title":"Journal of Biological Chemistry"},{"key":"5388_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100651","volume":"43","author":"TA Costa-Silva","year":"2020","unstructured":"Costa-Silva, T. A., Costa, I. M., Biasoto, H. P., Lima, G. M., Silva, C., Pessoa, A., & Monteiro, G. (2020). Critical overview of the main features and techniques used for the evaluation of the clinical applicability of L-asparaginase as a biopharmaceutical to treat blood cancer. Blood Reviews, 43, Article 100651. https:\/\/doi.org\/10.1016\/j.blre.2020.100651","journal-title":"Blood Reviews"},{"key":"5388_CR9","unstructured":"Brazilian Ministry of Health Report. Explanations L-asparaginase. (2017) Available at: https:\/\/www.gov.br\/saude\/pt-br\/acesso-a-informacao\/gestao-do-sus\/articulacao-interfederativa\/cit\/pautas-de-reunioes-e-resumos-cit\/2017\/junho\/2-b-l-asparaginase_cit_22_06_2017.pdf. Accessed 22 Aug. 2024."},{"key":"5388_CR10","doi-asserted-by":"publisher","unstructured":"Lopes, A. M., Oliveira-Nascimento, L., Ribeiro, A., Jr, T. C. A., Breyer, C. A., Oliveira, M. A., Monteiro, G., Souza-Motta, C. M., Magalh\u00e3es, P. O., Avenda\u00f1o, J. G., Cavaco-Paulo, A. M., Mazzola, P. G., Rangel-Yagui, C. O., Sette, L. D., Converti, A., & Pessoa, A. (2017). Therapeutic l-asparaginase: Upstream, downstream and beyond. Critical Reviews in Biotechnology, 37(1), 82\u201399. https:\/\/doi.org\/10.3109\/07388551.2015.1120705","DOI":"10.3109\/07388551.2015.1120705"},{"key":"5388_CR11","doi-asserted-by":"publisher","unstructured":"Barros, T., Brumano, L., Freitas, M., Pessoa, A. Jr., Parachin, N., Magalh\u00e3es, P. O. (2020) Development of processes for recombinant L-asparaginase II production by Escherichia coli Bl21 (De3): From Shaker to Bioreactors. Pharmaceutics. 13(1), 14, 1\u201315. https:\/\/doi.org\/10.3390\/pharmaceutics13010014.","DOI":"10.3390\/pharmaceutics13010014"},{"issue":"spe","key":"5388_CR12","doi-asserted-by":"publisher","DOI":"10.1590\/s2175-97902018000001009","volume":"54","author":"JHPM Santos","year":"2018","unstructured":"Santos, J. H. P. M., Torres-Obreque, K. M., Meneguetti, G. P., Amaro, B. P., & Rangel-Yagui, C. O. (2018). Protein PEGylation for the design of biobetters: From reaction to purification processes. Brazilian Journal of Pharmaceutical Sciences, 54(spe), Article e01009. https:\/\/doi.org\/10.1590\/s2175-97902018000001009","journal-title":"Brazilian Journal of Pharmaceutical Sciences"},{"issue":"4","key":"5388_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/BF03261880","volume":"26","author":"C Zhang","year":"2012","unstructured":"Zhang, C., Yang, X. L., Yuan, Y. H., Pu, J., & Liao, F. (2012). Site-specific PEGylation of therapeutic proteins via optimization of both accessible reactive amino acid residues and PEG derivatives. BioDrugs, 26(4), 209\u2013215. https:\/\/doi.org\/10.1007\/BF03261880","journal-title":"BioDrugs"},{"issue":"16","key":"5388_CR14","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.4155\/fmc.14.125","volume":"6","author":"C Ginn","year":"2014","unstructured":"Ginn, C., Khalili, H., Lever, R., & Brocchini, S. (2014). Pegylation and its impact on the design of new protein-based medicines. Future Medicinal Chemistry, 6(16), 1829\u20131846. https:\/\/doi.org\/10.4155\/fmc.14.125","journal-title":"Future Medicinal Chemistry"},{"issue":"2","key":"5388_CR15","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","volume":"105","author":"PL Turecek","year":"2016","unstructured":"Turecek, P. L., Bossard, M. J., Schoetens, F., & Ivens, I. A. (2016). PEGylation of biopharmaceuticals: A review of chemistry and nonclinical safety information of approved drugs. Journal of Pharmaceutical Sciences, 105(2), 460\u2013475. https:\/\/doi.org\/10.1016\/j.xphs.2015.11.015","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"5388_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10600","volume":"9","author":"Y Gao","year":"2024","unstructured":"Gao, Y., Joshi, M., Zhao, Z., & Mitragotri, S. (2024). PEGylated therapeutics in the clinic. Bioengineering & Translational Medicine, 9(1), Article e10600. https:\/\/doi.org\/10.1002\/btm2.10600","journal-title":"Bioengineering & Translational Medicine"},{"issue":"13","key":"5388_CR17","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.addr.2009.02.010","volume":"61","author":"G Pasut","year":"2009","unstructured":"Pasut, G., & Veronese, F. M. (2009). PEG conjugates in clinical development or use as anticancer agents: An overview. Advanced Drug Delivery Reviews, 61(13), 1177\u20131188. https:\/\/doi.org\/10.1016\/j.addr.2009.02.010","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1","key":"5388_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/biot.200900218","volume":"5","author":"S Jev\u0161evar","year":"2010","unstructured":"Jev\u0161evar, S., Kunstelj, M., & Porekar, V. G. (2010). PEGylation of therapeutic proteins. Biotechnology Journal, 5(1), 113\u2013128. https:\/\/doi.org\/10.1002\/biot.200900218","journal-title":"Biotechnology Journal"},{"key":"5388_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jconrel.2014.02.002","volume":"180","author":"D Pfister","year":"2014","unstructured":"Pfister, D., & Morbidelli, M. (2014). Process for protein PEGylation. Journal of Controlled Release, 180, 134\u2013149. https:\/\/doi.org\/10.1016\/j.jconrel.2014.02.002","journal-title":"Journal of Controlled Release"},{"issue":"7","key":"5388_CR20","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1021\/bm200541r","volume":"12","author":"X Shang","year":"2011","unstructured":"Shang, X., Yu, D., & Ghosh, R. (2011). Integrated solid-phase synthesis and purification of PEGylated protein. Biomacromolecules, 12(7), 2772\u20132779. https:\/\/doi.org\/10.1021\/bm200541r","journal-title":"Biomacromolecules"},{"issue":"3","key":"5388_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/bab.1723","volume":"66","author":"K Torres-Obreque","year":"2019","unstructured":"Torres-Obreque, K., Meneguetti, G. P., Cust\u00f3dio, D., Monteiro, G., Pessoa-Junior, A., & Rangel-Yagui, C. O. (2019). Production of a novel N-terminal PEGylated crisantaspase. Biotechnology and Applied Biochemistry, 66(3), 281\u2013289. https:\/\/doi.org\/10.1002\/bab.1723","journal-title":"Biotechnology and Applied Biochemistry"},{"key":"5388_CR22","unstructured":"Petrides, D. P., Koulouris, A., Lagonikos, P. T. (2002) The role of process simulation in pharmaceutical process development and product commercialization. 22 (1), 1\u201332. Available at https:\/\/ispe.org\/sites\/default\/files\/attachments\/public\/Jan-Feb-2002.pdf. Accessed 07 Nov. 2024."},{"issue":"4","key":"5388_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/bioengineering1040154","volume":"1","author":"D Petrides","year":"2014","unstructured":"Petrides, D., Carmichael, D., Siletti, C., & Koulouris, A. (2014). Biopharmaceutical process optimization with simulation and scheduling tools. Bioengineering (Basel), 1(4), 154\u2013187. https:\/\/doi.org\/10.3390\/bioengineering1040154","journal-title":"Bioengineering (Basel)"},{"issue":"1","key":"5388_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5581\/1516-8484.20120001","volume":"34","author":"CA de Souza","year":"2012","unstructured":"de Souza, C. A. (2012). What is happening with the supply of oncology drugs in Brazil and the world? Revista Brasileira de Hematologia e Hemoterapia, 34(1), 1\u20132. https:\/\/doi.org\/10.5581\/1516-8484.20120001","journal-title":"Revista Brasileira de Hematologia e Hemoterapia"},{"issue":"3","key":"5388_CR25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0958-1669(05)80142-9","volume":"2","author":"D Riesenberg","year":"1991","unstructured":"Riesenberg, D. (1991). High-cell-density cultivation of Escherichia coli. Current Opinion in Biotechnology, 2(3), 380\u2013384. https:\/\/doi.org\/10.1016\/S0958-1669(05)80142-9","journal-title":"Current Opinion in Biotechnology"},{"key":"5388_CR26","doi-asserted-by":"publisher","unstructured":"Heinzle, E.; Biwer, A. P.; Cooney, C. L. Development of sustainable bioprocesses: Modeling and assessment. John Wiley & Sons Ltd. First published: 17 November 2006. https:\/\/doi.org\/10.1002\/9780470058916.","DOI":"10.1002\/9780470058916"},{"key":"5388_CR27","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s002530050855","volume":"46","author":"U Horn","year":"1996","unstructured":"Horn, U., Strittmatter, W., Krebber, A., et al. (1996). High volumetric yields of functional dimeric miniantibodies in Escherichia coli, using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions. Applied Microbiology and Biotechnology, 46, 524\u2013532. https:\/\/doi.org\/10.1007\/s002530050855","journal-title":"Applied Microbiology and Biotechnology"},{"key":"5388_CR28","doi-asserted-by":"publisher","unstructured":"Ferreira, R. G., Azzoni, A.R. Freitas, S. (2018) Techno-economic analysis of the industrial production of a low-cost enzyme using E. coli: The case of recombinant \u03b2-glucosidase. Biotechnol Biofuels 11 (81), 1\u201313. https:\/\/doi.org\/10.1186\/s13068-018-1077-0.","DOI":"10.1186\/s13068-018-1077-0"},{"key":"5388_CR29","unstructured":"US Bureau of Labor Statistics Hourly Mean Wage for Chemical Equipment Operators and Tenders in Chemical Manufacturing in the United States. Available online: https:\/\/beta.bls.gov\/dataViewer\/view\/timeseries\/OEUN000000032500051901103 (accessed on 10 September 2024)."},{"key":"5388_CR30","unstructured":"US International Trade Commission. US International Trade Commission Dataweb. Available online: https:\/\/dataweb.usitc.gov\/trade\/search\/ (accessed on 8 September 2024)."},{"issue":"2","key":"5388_CR31","first-page":"1","volume":"30","author":"A Toumi","year":"2010","unstructured":"Toumi, A., J\u00fcrgens, C., Jungo, C., Maier, B. A., Papavasileioum, V., & Petrides, D. P. (2010). Design and optimization of a large scale biopharmaceutical facility using process simulation and scheduling tools. Phamaceutical Engineering, 30(2), 1\u20139.","journal-title":"Phamaceutical Engineering"},{"issue":"241","key":"5388_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pr9020241","volume":"9","author":"RG Ferreira","year":"2021","unstructured":"Ferreira, R. G., Azzoni, A. R., Santana, M. H. A., & Petrides, D. (2021). Techno-economic analysis of a hyaluronic acid production process utilizing streptococcal fermentation. Processes., 9(241), 1\u201316. https:\/\/doi.org\/10.3390\/pr9020241","journal-title":"Processes."},{"key":"5388_CR33","doi-asserted-by":"publisher","unstructured":"Barros, T., Brumano, L., Freitas, M., Pessoa, A., Junior, Parachin, N., Magalh\u00e3es, P.O. Development of processes for recombinant L-asparaginase II production by Escherichia coli Bl21(DE3): From shaker to bioreactors. Pharmaceutics. 13 (1) 14 (2021) 1\u201315. https:\/\/doi.org\/10.3390\/pharmaceutics13010014.","DOI":"10.3390\/pharmaceutics13010014"},{"issue":"1430","key":"5388_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pr9081430","volume":"9","author":"RG Ferreira","year":"2021","unstructured":"Ferreira, R. G., Gordon, N. F., Stock, R., & Petrides, D. (2021). Adenoviral vector COVID-19 vaccines: Process and cost analysis. Processes., 9(1430), 1\u201322. https:\/\/doi.org\/10.3390\/pr9081430","journal-title":"Processes."},{"issue":"2","key":"5388_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211951","volume":"14","author":"GP Meneguetti","year":"2019","unstructured":"Meneguetti, G. P., Santos, J. H. P. M., Obreque, K. M. T., Barbosa, C. M. V., Monteiro, G., Farsky, S. H. P., Marim de Oliveira, A., Angeli, C. B., Palmisano, G., Ventura, S. P. M., Pessoa-Junior, A., & de Oliveira Rangel-Yagui, C. (2019). Novel site-specific PEGylated L-asparaginase. PLoS One, 14(2), Article e0211951. https:\/\/doi.org\/10.1371\/journal.pone.0211951","journal-title":"PLoS One"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-025-05388-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-025-05388-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-025-05388-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T07:05:13Z","timestamp":1763622313000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-025-05388-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["5388"],"URL":"https:\/\/doi.org\/10.1007\/s12010-025-05388-w","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,11]]},"assertion":[{"value":"23 September 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain studies with human participants or animals. Hence, no formal consent is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Consent was obtained from all individual participants included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All the participants have consented to the publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Rafael G. Ferreira works for the company that develops and markets SuperPro Designer, the process simulation tool used in this work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}